Photocure (Norway) Performance
| PHO Stock | NOK 48.70 1.80 3.56% |
Photocure has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.21, which implies not very significant fluctuations relative to the market. As returns on the market increase, Photocure's returns are expected to increase less than the market. However, during the bear market, the loss of holding Photocure is expected to be smaller as well. Photocure right now holds a risk of 2.33%. Please check Photocure expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to decide if Photocure will be following its historical price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Photocure are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Photocure is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 334.9 M | |
| Total Cashflows From Investing Activities | -1.9 M |
Photocure |
Photocure Relative Risk vs. Return Landscape
If you would invest 4,985 in Photocure on August 28, 2024 and sell it today you would earn a total of 65.00 from holding Photocure or generate 1.3% return on investment over 90 days. Photocure is generating 0.0461% of daily returns assuming 2.3308% volatility of returns over the 90 days investment horizon. Simply put, 20% of all stocks have less volatile historical return distribution than Photocure, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Photocure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Photocure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Photocure, and traders can use it to determine the average amount a Photocure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0198
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PHO |
Estimated Market Risk
| 2.33 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Photocure is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Photocure by adding it to a well-diversified portfolio.
Photocure Fundamentals Growth
Photocure Stock prices reflect investors' perceptions of the future prospects and financial health of Photocure, and Photocure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Photocure Stock performance.
| Return On Equity | -0.16 | |||
| Return On Asset | -0.0309 | |||
| Profit Margin | (0.20) % | |||
| Operating Margin | (0.1) % | |||
| Current Valuation | 2.77 B | |||
| Shares Outstanding | 27.11 M | |||
| Price To Earning | 91.78 X | |||
| Price To Book | 6.33 X | |||
| Price To Sales | 7.76 X | |||
| Revenue | 360.54 M | |||
| EBITDA | 16.3 M | |||
| Cash And Equivalents | 319.04 M | |||
| Cash Per Share | 4.20 X | |||
| Total Debt | 12.5 M | |||
| Debt To Equity | 5.50 % | |||
| Book Value Per Share | 17.69 X | |||
| Cash Flow From Operations | 23.89 M | |||
| Earnings Per Share | (2.53) X | |||
| Total Asset | 789.65 M | |||
| Retained Earnings | 153 M | |||
| Current Asset | 195 M | |||
| Current Liabilities | 32 M | |||
About Photocure Performance
By examining Photocure's fundamental ratios, stakeholders can obtain critical insights into Photocure's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Photocure is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment in Nordic countries and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway. PHOTOCURE ASA operates under Drug Manufacturers - Major classification in Norway and is traded on Oslo Stock Exchange. It employs 71 people.Things to note about Photocure performance evaluation
Checking the ongoing alerts about Photocure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Photocure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 360.54 M. Net Loss for the year was (30.9 M) with profit before overhead, payroll, taxes, and interest of 336.49 M. |
- Analyzing Photocure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Photocure's stock is overvalued or undervalued compared to its peers.
- Examining Photocure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Photocure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Photocure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Photocure's stock. These opinions can provide insight into Photocure's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Photocure Stock
Photocure financial ratios help investors to determine whether Photocure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Photocure with respect to the benefits of owning Photocure security.